oxytocin treatment

Phase 1Small molecule

UUniversity of Electronic Science and Technology of China

oxytocin treatment is one of 14 small molecule programs targeting Attention. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AttentionRecruiting

ToleranceCompleted

AttentionPhase 1

Recruiting

TolerancePreclinical

Completed

Competition

Competitive Landscape

12 competitors in Tolerance

#DrugCompanyPhaseTrials

Rituxan

Roche

Phase 3

6 2

Fludara

Sanofi

Phase 2

2 3

Avigan

AAppili Therapeutics Inc.

Phase 2

2 4

Cytoxan

BBaxter Healthcare Corporation

Phase 2

2 5

Siplizumab

UUniversity of Alabama at Birmingham

Phase 2

1 6

Experimental

Biogen

Preclinical

1 7

oxytocin treatment

UUniversity of Electronic Science and Technology of China

Phase 1

1 8

Levo-Dromoran

VValeant Pharmaceuticals

Preclinical

1 9

Tazorac

FFougera Pharmaceuticals Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Attention4 trials

Oxytocin Effect on Attention Inhibition

Completed·UUniversity of Electronic Science and Technology of China·N/A·NCT03486925·71 enrolled

Oxytocin's Effects on Face Attentional Processing

Completed·UUniversity of Electronic Science and Technology of China·N/A·NCT04413786·60 enrolled

The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )

Recruiting·UUniversity of Electronic Science and Technology of China·Phase 1·NCT07140237·250 enrolled

Show 1 more trial

The Effect of Oral Oxytocin and Atosiban on Social Attention

Recruiting·UUniversity of Electronic Science and Technology of China·Phase 1·NCT07093060·250 enrolled

Oxytocin2 trials

Oxytocin's Effect on Social Pain Empathy

Unknown status·UUniversity of Electronic Science and Technology of China·N/A·NCT03122067·60 enrolled

The Role of Oxytocin in Modulating the Effects of Social Feedback on Achieving Personal Goals

Completed·UUniversity of Electronic Science and Technology of China·Phase 1·NCT02740101·62 enrolled

Tolerance1 trial

Oxytocin Effects on the Tolerance of Infidelity

Completed·UUniversity of Electronic Science and Technology of China·N/A·NCT02733237·160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for oxytocin treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — oxytocin treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for oxytocin treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Electronic Science and Technology of China company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: UUniversity of Electronic Science and Technology of China

oxytocin treatment

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Attention4 trials

Oxytocin2 trials

Tolerance1 trial

References

Drug Info

Quick Facts

Related News